US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist
  • 2.330
  • 0.0000.00%
Close Feb 28 16:00 ET
  • 2.330
  • 0.0000.00%
Post 16:05 ET
171.57MMarket Cap-15.53P/E (TTM)

Protalix Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Protalix Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.600M--
--2024/Q4-- / 18.746M--
Nov 14, 20242024/Q317.839M / 16.258M--
Aug 14, 20242024/Q213.304M / 12.500M--
May 10, 20242024/Q13.677M / 9.200M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.600M--
--2024/Q4-- / 18.746M--
Nov 14, 20242024/Q317.839M / 16.258M--
Aug 14, 20242024/Q213.304M / 12.500M--
May 10, 20242024/Q13.677M / 9.200M--

Unlock Free Earnings Estimates

Protalix Biotherapeutics Earnings Reports

  • Protalix Biotherapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 07:07 ET

  • Protalix Biotherapeutics | 8-K: Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results

    Nov 14, 2024 07:02 ET

  • Protalix Biotherapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 07:06 ET

  • Protalix Biotherapeutics | 8-K: Protalix BioTherapeutics Reports Second Quarter 2024 Financial and Business Results

    Aug 14, 2024 06:59 ET

    • Read more

    Trending Stocks

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    LINTEX
    920106
    +30.00%
    LINGOOD
    833284
    +29.98%
    NTGEC
    870436
    +29.98%
    4
    CG MED EQUIP.
    838810
    +29.97%
    5
    Jiayu Holding
    300117
    +20.48%
    Log In for the Full List
    Unlock Now
    Investment Course
    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
    Monetary Policy: Navigating the Fed's Rate Cut Cycle
    Changing Fed policy is altering the market math for investors.
    Discussing
    Big Tech’s earnings season in full swing! Nvidia is the only one left
    On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
    AMZN earnings preview: Grab rewards by guessing the opening price!